Assistant Professor, Pathology; Feinberg School of Medicine
View Publications Listing
Dr. Kulesza is a pathologist/scientist. Within the Cancer Center he serves as the Director of the Pathology Core Facility and the Director of the Eastern Oncology Cooperative Group (ECOGACRIN) Pathology Coordinating Office and Reference Laboratory. He is triple-boarded (Anatomic Pathology, Clinical Pathology, Cytopathology) and has scientific experience as PI of externally funded laboratory, as well as administrative and regulatory experience (Food and Drug Administration Advisory Panel on Pathology and Hematology). He has practiced as an attending pathologist for more than six years, both in the context of clinical trials where he designed and performed the tissue procurement and tissue arrays, as well as in routine medical care. His laboratory (independent of the Pathology Core Facility he currently directs) has been involved in the development of live tumor assays, both in the context of xenografting, as well as rapid molecular analysis in vitro. He has developed expertise in handling and analysis of live tumor specimens in much collaboration since 2005. He published on optimal sample handling in lymphoma and filed his first patent regarding “Rapid Prognostic Assay for Malignancies Treated with EGFR Inhibitors” in 2005. Finally, Dr. Kulesza serves as a member of the ECOG Laboratory Sciences and Pathology Committee and the NCI Cooperative Group Bio-Repository Committee.